In vitro antibody affinity maturation targeting germline hotspots.

Area of Science:

• Immunology
• Biotechnology
• Molecular Biology

Background:

• Antibody affinity is crucial for therapeutic efficacy, with higher affinity potentially allowing lower dosages and reduced toxicity.
• Affinity maturation in the immune system involves somatic hypermutations, suggesting germline residues are key targets for improvement.
• Current antibody engineering may require enhanced affinity for optimal therapeutic applications.

Purpose of the Study:

• To describe procedures for germline hotspot mutagenesis to improve antibody affinity.
• To present strategies for randomizing germline hotspots using PCR and phage display.
• To exemplify these methods using an anti-CD22 monoclonal antibody.

Main Methods:

• Utilizing polymerase chain reaction (PCR) for targeted mutagenesis of germline antibody hotspots.
• Employing phage display technology for the selection and screening of antibodies with improved affinity.
• Focusing on strategies for efficient randomization of specific hotspot residues.

Main Results:

• Demonstrated procedures for germline hotspot mutagenesis.
• Successfully applied PCR and phage display for randomizing hotspots in an antibody.
• Provided a practical example using an anti-CD22 monoclonal antibody.

Conclusions:

• Germline hotspot mutagenesis is a viable strategy for enhancing antibody affinity.
• PCR and phage display offer effective methods for antibody engineering and affinity maturation.
• Optimizing antibody affinity through targeted mutagenesis can lead to improved therapeutic agents.